Mannatech (NASDAQ:MTEX) Receives New Coverage from Analysts at StockNews.com

StockNews.com began coverage on shares of Mannatech (NASDAQ:MTEX) in a research note issued to investors on Sunday. The brokerage issued a buy rating on the stock.

Mannatech Stock Down 0.4 %

MTEX stock opened at $7.53 on Friday. The company has a market cap of $14.19 million, a PE ratio of -8.46 and a beta of 1.17. The company has a quick ratio of 0.62, a current ratio of 1.17 and a debt-to-equity ratio of 0.54. Mannatech has a 52 week low of $6.75 and a 52 week high of $11.80. The business has a 50-day simple moving average of $7.34 and a 200 day simple moving average of $7.75.

Mannatech (NASDAQ:MTEX) last issued its quarterly earnings results on Tuesday, August 13th. The company reported ($0.33) earnings per share for the quarter. The firm had revenue of $27.74 million for the quarter. Mannatech had a negative return on equity of 11.87% and a negative net margin of 0.97%.

Insider Activity

In related news, Director Larry A. Jobe sold 16,288 shares of the firm’s stock in a transaction dated Monday, September 9th. The stock was sold at an average price of $7.75, for a total value of $126,232.00. Following the sale, the director now directly owns 54,721 shares of the company’s stock, valued at $424,087.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 41.50% of the company’s stock.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.